139 related articles for article (PubMed ID: 35767557)
1. Follow-up PET/CT of alveolar echinococcosis: Comparison of metabolic activity and immunodiagnostic testing.
Husmann L; Deibel A; Skawran S; Ledergerber B; Muehlematter UJ; Hasse B; Huellner MW; Reiner CS; Muellhaupt B
PLoS One; 2022; 17(6):e0270695. PubMed ID: 35767557
[TBL] [Abstract][Full Text] [Related]
2. Prediction of benzimidazole therapy duration with PET/CT in inoperable patients with alveolar echinococcosis.
Husmann L; Gruenig H; Reiner CS; Deibel A; Ledergerber B; Liberini V; Skawran S; Muehlematter UJ; Messerli M; Hasse B; Muellhaupt B; Huellner MW
Sci Rep; 2022 Jul; 12(1):11392. PubMed ID: 35794149
[TBL] [Abstract][Full Text] [Related]
3. PET/CT helps to determine treatment duration in patients with resected as well as inoperable alveolar echinococcosis.
Husmann L; Muehlematter UJ; Grimm F; Ledergerber B; Messerli M; Kudura K; Gruenig H; Muellhaupt B; Hasse B; Huellner MW
Parasitol Int; 2021 Aug; 83():102356. PubMed ID: 33872794
[TBL] [Abstract][Full Text] [Related]
4. Diffusion-Weighted MRI for the Initial Viability Evaluation of Parasites in Hepatic Alveolar Echinococcosis: Comparison with Positron Emission Tomography.
Zheng J; Wang J; Zhao J; Meng X
Korean J Radiol; 2018; 19(1):40-46. PubMed ID: 29353998
[TBL] [Abstract][Full Text] [Related]
5. F-18-fluorodeoxyglucose (FDG) positron-emission tomography of Echinococcus multilocularis liver lesions: prospective evaluation of its value for diagnosis and follow-up during benzimidazole therapy.
Stumpe KD; Renner-Schneiter EC; Kuenzle AK; Grimm F; Kadry Z; Clavien PA; Deplazes P; von Schulthess GK; Muellhaupt B; Ammann RW; Renner EL
Infection; 2007 Feb; 35(1):11-8. PubMed ID: 17297583
[TBL] [Abstract][Full Text] [Related]
6. Determination of vitality of liver lesions by alveolar echinococcosis. Comparison of parametric contrast enhanced ultrasound (SonoVue®) with quantified 18F-FDG-PET-CT.
Kaltenbach TE; Graeter T; Mason RA; Kratzer W; Oeztuerk S; Haenle MM; Gruener B; Gottstein M
Nuklearmedizin; 2015; 54(1):43-9. PubMed ID: 25423884
[TBL] [Abstract][Full Text] [Related]
7. Assessment of disease activity in alveolar echinococcosis: a comparison of contrast enhanced ultrasound, three-phase helical CT and [(18)F] fluorodeoxyglucose positron emission tomography.
Ehrhardt AR; Reuter S; Buck AK; Haenle MM; Mason RA; Gabelmann A; Kern P; Kratzer W
Abdom Imaging; 2007 Nov; 32(6):730-6. PubMed ID: 17285403
[TBL] [Abstract][Full Text] [Related]
8. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and follow-up performance of serological tests for different forms/courses of alveolar echinococcosis.
Gottstein B; Lachenmayer A; Beldi G; Wang J; Merkle B; Vu XL; Kurath U; Müller N
Food Waterborne Parasitol; 2019 Sep; 16():e00055. PubMed ID: 32095626
[TBL] [Abstract][Full Text] [Related]
10. Comparison of [
Li J; Dong J; Yang L; Li X; Song T
Ultrasound Med Biol; 2018 Nov; 44(11):2199-2208. PubMed ID: 30077410
[TBL] [Abstract][Full Text] [Related]
11. The clinical consequences of functional adrenal uptake in the absence of cross-sectional mass on FDG-PET/CT in oncology patients.
Hsiao R; Chow A; Kluijfhout WP; Bongers PJ; Verzijl R; Metser U; Veit-Haibach P; Pasternak JD
Langenbecks Arch Surg; 2022 Jun; 407(4):1677-1684. PubMed ID: 34993609
[TBL] [Abstract][Full Text] [Related]
12. Biological characteristics of 18F-FDG PET/CT imaging of cerebral alveolar echinococcosis.
Yibulayin A; Li XH; Qin YD; Jia XY; Zhang QZ; Li YB
Medicine (Baltimore); 2018 Sep; 97(39):e11801. PubMed ID: 30278480
[TBL] [Abstract][Full Text] [Related]
13. FDG-PET/MRI imaging for the management of alveolar echinococcosis: initial clinical experience at a reference centre in Austria.
Lötsch F; Waneck F; Groger M; Auer H; Kaczirek K; Rausch I; Wadsak W; Hacker M; Lagler H; Ramharter M; Karanikas G
Trop Med Int Health; 2019 Jun; 24(6):663-670. PubMed ID: 30851233
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of metabolic activity in human alveolar echinococcosis using FDG-PET.
Reuter S; Grüner B; Buck AK; Blumstein N; Kern P; Reske SN
Nuklearmedizin; 2008; 47(4):147-52. PubMed ID: 18690373
[TBL] [Abstract][Full Text] [Related]
15. Assessment of treatment responses in children and adolescents with Ewing sarcoma with metabolic tumor parameters derived from
Schmidkonz C; Krumbholz M; Atzinger A; Cordes M; Goetz TI; Prante O; Ritt P; Schaefer C; Agaimy A; Hartmann W; Rössig C; Fröhlich B; Bäuerle T; Dirksen U; Kuwert T; Metzler M
Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1564-1575. PubMed ID: 31853559
[TBL] [Abstract][Full Text] [Related]
16. Utility of FDG PET/CT in the Characterization of Sinonasal Neoplasms: Analysis of Standardized Uptake Value Parameters.
Ozturk K; Gencturk M; Caicedo-Granados E; Li F; Cayci Z
AJR Am J Roentgenol; 2018 Dec; 211(6):1354-1360. PubMed ID: 30300005
[TBL] [Abstract][Full Text] [Related]
17.
Petrović J; Beatović S; Šobić-Šaranović D; Odalović S; Stojiljković M; Grozdic-Milojevic I; Veljkovic M; Jovanovic D; Artiko V
Hell J Nucl Med; 2022; 25(1):19-25. PubMed ID: 35388800
[TBL] [Abstract][Full Text] [Related]
18. Impact of maximum standardized uptake value (SUVmax) evaluated by 18-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (18F-FDG-PET/CT) on survival for patients with advanced renal cell carcinoma: a preliminary report.
Namura K; Minamimoto R; Yao M; Makiyama K; Murakami T; Sano F; Hayashi N; Tateishi U; Ishigaki H; Kishida T; Miura T; Kobayashi K; Noguchi S; Inoue T; Kubota Y; Nakaigawa N
BMC Cancer; 2010 Dec; 10():667. PubMed ID: 21129184
[TBL] [Abstract][Full Text] [Related]
19. Role of
Dolci C; Ceppi L; Guerra L; Crivellaro C; Lamanna M; Adorni M; Elisei F; Bonazzi CM; Sina F; Fruscio R; Messa C
Int J Gynecol Cancer; 2019 Oct; 29(8):1298-1303. PubMed ID: 31366569
[TBL] [Abstract][Full Text] [Related]
20. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
